Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: ASCO-OH (CCO) Guideline Update - Eisen, A; Somerfield, M R; Accordino, M K (J Clin Oncol, 2022)
et al.